We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

2 hedge funds and large institutions have $2.52K invested in Mirati Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 212 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 217 → 2 (-215)

100% less funds holding in top 10

Funds holding in top 10: 18 → 0 (-18)

100% less capital invested

Capital invested by funds: $5.02B → $2.52K (-$5.02B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 212

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-215
Holders Change %
-99.08%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
212
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$725M
2
EC
EcoR1 Capital
California
-$435M
3
RI
RTW Investments
New York
-$398M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$312M
5
ACA
Avoro Capital Advisors
New York
-$287M
Name Holding Trade Value Shares
Change 		Change in
Stake
S
1
Sachetta
Massachusetts
$1.41K – – –
IA
2
IFP Advisors
Florida
$1.11K -$216K -3,659 -99%
Morgan Stanley
3
Morgan Stanley
New York
– -$725M -12,338,764 Closed
EC
4
EcoR1 Capital
California
– -$435M -7,396,979 Closed
RI
5
RTW Investments
New York
– -$398M -6,768,514 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$312M -5,306,693 Closed
ACA
7
Avoro Capital Advisors
New York
– -$287M -4,886,840 Closed
BBA
8
Baker Bros. Advisors
New York
– -$242M -4,121,440 Closed
BlackRock
9
BlackRock
New York
– -$227M -3,866,202 Closed
BC
10
Boxer Capital
California
– -$188M -3,201,440 Closed
B
11
Braslyn
Bahamas
– -$184M -3,135,966 Closed
State Street
12
State Street
Massachusetts
– -$137M -2,324,268 Closed
FCM
13
Farallon Capital Management
California
– -$119M -2,024,472 Closed
AAM
14
Alpine Associates Management
Florida
– -$111M -1,881,400 Closed
TCM
15
Tang Capital Management
California
– -$91.5M -1,558,059 Closed
PBA
16
Paradigm Biocapital Advisors
New York
– -$90.7M -1,543,116 Closed
SCM
17
Sio Capital Management
New York
– -$85.3M -1,451,925 Closed
MP
18
Mangrove Partners
Connecticut
– -$64.7M -1,101,736 Closed
Bank of New York Mellon
19
Bank of New York Mellon
New York
– -$59.3M -1,010,099 Closed
Geode Capital Management
20
Geode Capital Management
Massachusetts
– -$57.6M -980,029 Closed
PCM
21
Pentwater Capital Management
Florida
– -$53M -902,632 Closed
RSCM
22
Rock Springs Capital Management
Maryland
– -$49.1M -835,776 Closed
MF
23
Magnetar Financial
Illinois
– -$49M -834,390 Closed
HSBC Holdings
24
HSBC Holdings
United Kingdom
– -$46M -783,092 Closed
Norges Bank
25
Norges Bank
Norway
– -$44.2M -751,604 Closed
1
2 3 4 5

MRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q1 2024, worth a combined $2.52K — down 100% from $5.02B a quarter earlier.

Sellers outnumbered buyers: 212 funds closed out of MRTX and 0 opened new positions — a net loss of 212 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $725M sold.

  • 2 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q1 2024, down from 217 in Q4 2023.
  • Funds reported $2.52K of Mirati Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q1 2024 and 212 closed out, a net change of -212 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $725M sold.

Based on aggregated 13F filings for Q1 2024.